“`html
Study Title
The influence of home versus clinic anal human papillomavirus sampling on high-resolution anoscopy uptake in the Prevent Anal Cancer Self-Swab Study
Key Findings
Anal cancer disproportionately affects sexual and gender minority individuals living with HIV. High-resolution anoscopy (HRA) is an in-clinic procedure to detect precancerous anal lesions and cancer. We examined whether anal HPV sampling at home versus in a clinic impacts HRA uptake and assessed HRA acceptability.
Results
A total of 62.8% of 196 participants who engaged in screening attended HRA. Although not significant (P =0.13), a higher proportion of participants who engaged in clinic-based screening attended HRA (68.5%) compared to home-based participants (57.9%). Overall, HRA uptake was higher among participants with anal cytology history and lower among participants preferring a versatile anal sex position versus insertive. In the clinic arm, persons living with HIV had lower HRA attendance (42.9%) versus HIV-negative participants (73.3%) and Black non-Hispanic participants had lower HRA attendance (41.7%) than White non-Hispanic participants (73.1%). No differences in attendance by race or HIV status were observed in the home arm. HRA uptake differed significantly by race and HIV status in the clinic arm but not the home arm.
Practical Solutions and Value
Clinical trials are key to developing safe and effective treatments. It’s important to extend their benefits into everyday medical practice. DocSym, our AI-driven platform, helps by consolidating ICD-11 standards, clinical protocols, and research into a single, easily accessible knowledge base for clinicians. In today’s healthcare environment, streamlining operations is crucial. Our mobile apps support scheduling, monitoring treatments, and telemedicine, making it easier to manage patient care and expand services digitally. By using AI, clinics can enhance their workflows and improve patient outcomes, reduce paper routine. Learn more about how we can help at aidevmd.com.
“`
